The Novo Nordisk Way is the values-based
governance framework for the company and is an integrated part of the
company’s corporate governance. Thus, our corporate governance
framework takes into consideration codes and regulations and the Novo
Novo Nordisk’s Novo Nordisk’s B shares are listed on Nasdaq Copenhagen and on the New York Stock Exchange (NYSE) as American Depository Receipts (ADRs). Novo Nordisk is in compliance with Danish and - as a foreign listed private issuer - US securities laws including the US Sarbanes-Oxley Act.
Further Novo Nordisk is in compliance with the majority (42 out of 47) of the Danish Corporate Governance Recommendations (2017). Also, Novo Nordisk is - as a foreign listed private issuer - in compliance with corporate governance standards on New York Stock Exchange (2013).
It is Novo Nordisk's intent to seek compliance and adapt its
procedures to align with current applicable codes to the extent
possible and desirable. See
a detailed review of Novo Nordisk's compliance with and
deviations from codes on corporate governance designated by Nasdaq
Copenhagen and the New York Stock Exchange.
Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. This statement expresses the Triple Bottom Line principle which is a lens for decision-making that supports long-term success by creating shared value for society and investors. It is anchored in the company’s Articles of Association and in the Novo Nordisk Way.
The Novo Nordisk Way is the values-based management system. It makes
it clear to employees what the company’s ambitions are, how it will
achieve them and what the organisation values are. It is supported by
specific policies in areas relevant across the organisation.
Novo Nordisk holds itself accountable to shareholders and other stakeholders for its performance. The accuracy, completeness and reliability of the information provided in the company's reporting are verified through internal controls, assurance and independent audits.
Reporting is a tool for shareholders to assess the actions of the Board of Directors, and shareholders can, at general meetings, query them. Integrity and values are the spine of Novo Nordisk's corporate culture and must never be compromised. These are essential elements of the control environment, affecting the design, administration, and monitoring of other internal control components.
This is the message conveyed to employees, as laid down by the Novo Nordisk Way.
* The Chairmanship is directly elected by the Annual General Meeting.